rs2420946

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000141.5(FGFR2):​c.109+1899A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.566 in 152,054 control chromosomes in the GnomAD database, including 24,551 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.57 ( 24551 hom., cov: 32)

Consequence

FGFR2
NM_000141.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.729

Publications

83 publications found
Variant links:
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
FGFR2 Gene-Disease associations (from GenCC):
  • Apert syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, G2P, Orphanet
  • Beare-Stevenson cutis gyrata syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, G2P
  • bent bone dysplasia syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • Crouzon syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Ambry Genetics, G2P
  • Jackson-Weiss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • LADD syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Pfeiffer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
  • familial scaphocephaly syndrome, McGillivray type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Saethre-Chotzen syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Antley-Bixler syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • LADD syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
  • Pfeiffer syndrome type 1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Pfeiffer syndrome type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Pfeiffer syndrome type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.606 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000141.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGFR2
NM_022970.4
MANE Plus Clinical
c.109+1899A>G
intron
N/ANP_075259.4P21802-3
FGFR2
NM_000141.5
MANE Select
c.109+1899A>G
intron
N/ANP_000132.3P21802-1
FGFR2
NM_001441087.1
c.109+1899A>G
intron
N/ANP_001428016.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FGFR2
ENST00000457416.7
TSL:1 MANE Plus Clinical
c.109+1899A>G
intron
N/AENSP00000410294.2P21802-3
FGFR2
ENST00000358487.10
TSL:1 MANE Select
c.109+1899A>G
intron
N/AENSP00000351276.6P21802-1
FGFR2
ENST00000369056.5
TSL:1
c.109+1899A>G
intron
N/AENSP00000358052.1P21802-17

Frequencies

GnomAD3 genomes
AF:
0.566
AC:
85936
AN:
151936
Hom.:
24537
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.475
Gnomad AMI
AF:
0.437
Gnomad AMR
AF:
0.575
Gnomad ASJ
AF:
0.575
Gnomad EAS
AF:
0.623
Gnomad SAS
AF:
0.610
Gnomad FIN
AF:
0.576
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.611
Gnomad OTH
AF:
0.568
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.566
AC:
85988
AN:
152054
Hom.:
24551
Cov.:
32
AF XY:
0.564
AC XY:
41928
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.475
AC:
19667
AN:
41440
American (AMR)
AF:
0.575
AC:
8788
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
1993
AN:
3468
East Asian (EAS)
AF:
0.623
AC:
3222
AN:
5168
South Asian (SAS)
AF:
0.609
AC:
2937
AN:
4820
European-Finnish (FIN)
AF:
0.576
AC:
6092
AN:
10572
Middle Eastern (MID)
AF:
0.558
AC:
164
AN:
294
European-Non Finnish (NFE)
AF:
0.611
AC:
41523
AN:
67994
Other (OTH)
AF:
0.571
AC:
1205
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1920
3840
5760
7680
9600
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.597
Hom.:
53781
Bravo
AF:
0.561
Asia WGS
AF:
0.606
AC:
2107
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.15
DANN
Benign
0.37
PhyloP100
-0.73
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2420946; hg19: chr10-123351324; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.